A Study of Treatment Choices in Men with Erectile Dysfunction and Reduced Androgen Levels

Abstract

A large cohort of men presenting with erectile dysfunction were offered concurrent measurement of serum total testosterone. Just over one sixth (17.7%) of the initial screening values of patients suggested the possibility of hypogonadism, however, when more rigorous estimation of serum testosterone and associated parameters and the presence of clinical symptoms were applied, 3% of the population had hypergonadotropic hypogonadism. Only 10 of 44 (22.7%) eligible men agreed to a trial of testosterone therapy, however, two thirds of this eligible group also required another erectogenic agent to resolve the erectile dysfunction.